APA (7th ed.) Citation

Z, C., H, H., Y, S., M, Y., T, T., S, N., . . . Z, L. (2026). Targeting the exosomal CaMK2A-ZDHHC3-GPX4 pathway reprograms tumor-associated macrophages and enhances anti-PD-1/PD-L1 immunotherapy in gastric cancer. International journal of biological sciences, 22(11), 5659. https://doi.org/10.7150/ijbs.128976

Chicago Style (17th ed.) Citation

Z, Chen, Huang H, Shen Y, Yamamoto M, Tsukamoto T, Nomura S, Jiang T, Xu Z, and Li Z. "Targeting the Exosomal CaMK2A-ZDHHC3-GPX4 Pathway Reprograms Tumor-associated Macrophages and Enhances Anti-PD-1/PD-L1 Immunotherapy in Gastric Cancer." International Journal of Biological Sciences 22, no. 11 (2026): 5659. https://doi.org/10.7150/ijbs.128976.

MLA (9th ed.) Citation

Z, Chen, et al. "Targeting the Exosomal CaMK2A-ZDHHC3-GPX4 Pathway Reprograms Tumor-associated Macrophages and Enhances Anti-PD-1/PD-L1 Immunotherapy in Gastric Cancer." International Journal of Biological Sciences, vol. 22, no. 11, 2026, p. 5659, https://doi.org/10.7150/ijbs.128976.